Home Biovista

Biovista

In operation
-
Artificial Intelligence System Development Company
Basic
Enterprise Profile

Basic Information

Biovista is a pioneer in AI and systematic drug repositioning. We apply our systematic approach to develop an AI platform, advancing our candidate drugs in disease areas such as neurodegenerative diseases, epilepsy, oncology, and rare diseases. We also collaborate with partners on both new chemical entities and existing compounds.
Biovista Personalized Medicine
Virginia,United States of America
15~50 people
January 01, 1999
info@biovista.com

Enterprise Profile

Industrial Sector
New Drug Development CXO (Pharmaceutical Outsourcing Organization)
Technology
Artificial Intelligence
Concept
Tumor Rare Diseases Epilepsy
Application Scenarios
Innovative Drugs AI+Pharmaceuticals